Similar findings were obtained when anti-PD-1 (clone RMP1–14) and PEGPH20 were combined (tumor growth inhibition: 56%, p = 0.020 and 0.017, respectively, compared with anti-PD-1 or PEGPH20 alone) [64]. The gene discussed is PDCD1; the disease is neoplasm.